Onconetix Inc.
02/09/2026 | Press release | Distributed by Public on 02/09/2026 16:00
Proxy Results (Form 8-K)
Item 5.07 Submission of Matters to a Vote of Security Holders.
On February 3, 2026, Onconetic, Inc. (the "Company") held a special meeting of stockholders (the "Special Meeting"). The matters voted on at the Special Meeting were:
| (1) | the approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of all of the outstanding shares of the Company's common stock, par value $0.00001 per share ("Common Stock"), at a ratio in the range of 1-for-2 to 1-for-50, at any time prior to the one-year anniversary date of the special meeting, with such ratio to be determined by the Board of Directors without further approval or authorization of our stockholders (the "Reverse Stock Split Proposal") |
| (2) | the approval the adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the Reverse Stock Split Proposal. (the "Adjournment Proposal") |
At the Special Meeting, all of the matters voted on were approved, based upon an aggregate of 1,555,015 shares of Common Stock outstanding as of December 12, 2025, the record date for the Special Meeting. The final voting results were as follows:
1. Reverse Stock Split Proposal
The votes were cast for this matter as follows:
| Votes For | Votes Against | Abstentions | ||||||||
| 562,803 | 123,144 | 986 | ||||||||
2. The Adjournment Proposal.
The votes were cast for this matter as follows:
| Votes For | Votes Against | Abstentions | ||||||||
| 567,357 | 118,604 | 972 | ||||||||
Onconetix Inc. published this content on February 09, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 09, 2026 at 22:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]